[AI] Fwd: RP . . . Dr Sapse Stem Cell treatment in India
mufshi at hotmail.com
Mon Jul 16 10:57:53 EDT 2007
this item was discussed some time back on the list and i wish to know if
development on this front has come into being in effect.
do inform more about this on the list if anyone knows more.
----- Original Message -----
From: "Rajesh Kankaria" <rkcoral at gmail.com>
To: <accessindia at accessindia.org.in>
Sent: Sunday, April 29, 2007 10:38 PM
Subject: [AI] Fwd: RP . . . Dr Sapse Stem Cell treatment in India
> Sorry if its already discussed/posted here.
> Prakash took his wife to US this month early to get his wife's
> stem-cell treatment done. We are expecting the results to come after
> 6th week of the surgery (i.e. around 21-23 may'07)
> Further if we have any doctor from UK here who can attend Dr Sapse
> view/opinion/paper being presented on 1st-2nd and 3rd May'07.
> ---------- Forwarded message ----------
> From: Rajesh Kankaria <rkcoral at gmail.com>
> Date: Apr 29, 2007 3:36 PM
> thnx for the info. Prakash has mentioned that Dr Sapse n his team is
> coming to India (guess to Ludhiana) in May (dunno the dates yet) for
> this agreement signup.
> Not too sure abt Mr Lal's background though. anyone can inquire
> further n post here it would be great.
> On 4/29/07, Rounak Singhania <rounak_singhania at yahoo.co.in> wrote:
>> Got the message below from orkut .
>> Stem cell treatment for RP in India now
>> Stem Cell Pharma Inc. (SCPI), (USA) and King Multitech Global PvT Limited
>> (KMT), (INDIA) announce the signing April 12th, 2007 of a joint venture
>> the opening of a Retinitis Pigmentosa (RP) Center in Ludhiana, Punjab,
>> INDIA. This Center, the first of its type in the world, would treat RP
>> with an amniotic membrane derived, embryonic Stem Cells Implant developed
>> Dr. Alfred T. Sapse, the President of SCPI. The implant had shown
>> beneficial results when used in RP patients.
>> When becoming functional, estimated date October 2007, the Center will
>> an amniotic tissue bank where amnions can be collected, stored, and used,
>> with our US, FDA approved Good Tissue Practices (GTP) bank, also
>> for opthalmological examinations, electroretinogram (ERG) and others. The
>> Center will have an initial staff of five MDs trained in the art of the
>> Implant and additional personnel, and being able to perform initially
>> Cell implants a day, at prices compatible with the prices charged in the
>> Details about the Retinitis Pigmentosa Center will be provided by
>> of both parties at the European Stem Cell Congress, May 1-3, 2007 at the
>> Hotel in London, UK. There will also be a presentation of an RP case, a
>> gentleman that has received the stem cells implant, and snap shots of the
>> cell procedure. His father, Mr. Madan Lal, is the President of King
>> Exports/KMT, our joint venture partner who dedicates this JV Center to
>> many of
>> the 392,000 patients with RP in India, for which there was no known
>> treatment, until now.
>> We are confident that the Center would be a success.
> To unsubscribe send a message to accessindia-request at accessindia.org.in
> with the subject unsubscribe.
> To change your subscription to digest mode or make any other changes,
> please visit the list home page at
More information about the AccessIndia